Abstract
We aimed to investigate preventive effects of All-trans retinoic acid (ATRA) on a lipopolysaccharide (LPS)-induced aged neuroinflammation model. We analyzed behavior, systemic nitric oxide (NO) production, cerebral NO synthase (NOS2) and β-amyloid (Aβ) 1-42 expression and tissue integrity in the neuroinflammation model pretreated with ATRA (150μg/ml/rat/day) for 30days. Our results showed that LPS treatment (500μg/kg/day) for 7days disturbed memory, enhanced systemic NO production, NOS2 and Aβ 1-42 cerebral expression and generated an Alzheimer's disease (AD)-like neuronal degeneration. Interestingly, ATRA pretreatment prevented the LPS-induced deleterious effects. ATRA could be a potent preventive approach in AD.
Keywords:
Aging; All-trans retinoic acid; Alzheimer's disease; Inducible nitric oxide synthase; Neuroinflammation.
Copyright © 2016 Elsevier B.V. All rights reserved.
MeSH terms
-
Aging / drug effects
-
Aging / metabolism*
-
Aging / pathology
-
Alzheimer Disease / metabolism*
-
Alzheimer Disease / pathology
-
Alzheimer Disease / prevention & control
-
Amyloid beta-Peptides / antagonists & inhibitors
-
Amyloid beta-Peptides / biosynthesis*
-
Animals
-
Brain / drug effects
-
Brain / metabolism
-
Brain / pathology
-
Inflammation / metabolism
-
Inflammation / pathology
-
Inflammation / prevention & control
-
Lipopolysaccharides / toxicity
-
Male
-
Memory Disorders / metabolism*
-
Memory Disorders / pathology
-
Memory Disorders / prevention & control
-
Neuroprotective Agents / pharmacology
-
Neuroprotective Agents / therapeutic use*
-
Nitric Oxide Synthase Type II / biosynthesis
-
Peptide Fragments / antagonists & inhibitors
-
Peptide Fragments / biosynthesis*
-
Rats
-
Rats, Wistar
-
Tretinoin / therapeutic use*
Substances
-
Amyloid beta-Peptides
-
Lipopolysaccharides
-
Neuroprotective Agents
-
Peptide Fragments
-
amyloid beta-protein (1-42)
-
Tretinoin
-
Nitric Oxide Synthase Type II
-
Nos2 protein, rat